CCO Reading Tools
How to cite item
Tislelizumab plus chemotherapy
vs
. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{CCO}{117719}, author = {Messori, A., Rivano, M., Chiumente, M., Mengato, D.}, title = {Tislelizumab plus chemotherapy
vs
. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials}, journal = {Chinese Clinical Oncology}, volume = {12}, number = {5}, year = {2023}, url = {https://cco.amegroups.org/article/view/117719} }